Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentoxifylline add-on for bipolar depression
IRCT20201119049445N3Phase 2Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in bipolar disorder (BD) comparing Pentoxifylline add-on arm with Placebo add-on control arm (2 arms). Primary endpoint: Bipolar Depression Rating Scale score at week 8. Started Jun 2022; status: completed.
02
Drugs
pentoxifylline
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on IRCT20201119049445N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20201119049445N3.